EARNEST Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,767
| Closed | -$117K | – | 1173 |
|
2023
Q2 | $117K | Sell |
2,767
-2,590,741
| -100% | -$109M | ﹤0.01% | 297 |
|
2023
Q1 | $92.4M | Buy |
2,593,508
+1,093,222
| +73% | +$38.9M | 0.53% | 82 |
|
2022
Q4 | $55M | Buy |
1,500,286
+8,658
| +0.6% | +$318K | 0.34% | 118 |
|
2022
Q3 | $70.3M | Buy |
1,491,628
+35,533
| +2% | +$1.68M | 0.47% | 90 |
|
2022
Q2 | $104M | Buy |
1,456,095
+295,380
| +25% | +$21.2M | 0.7% | 57 |
|
2022
Q1 | $94M | Buy |
1,160,715
+22,704
| +2% | +$1.84M | 0.56% | 73 |
|
2021
Q4 | $117M | Buy |
1,138,011
+38,663
| +4% | +$3.97M | 0.67% | 52 |
|
2021
Q3 | $96.2M | Buy |
1,099,348
+22,015
| +2% | +$1.93M | 0.59% | 64 |
|
2021
Q2 | $96.4M | Buy |
1,077,333
+50,793
| +5% | +$4.55M | 0.57% | 73 |
|
2021
Q1 | $77.9M | Buy |
1,026,540
+124,242
| +14% | +$9.42M | 0.47% | 85 |
|
2020
Q4 | $61.5M | Buy |
902,298
+237,282
| +36% | +$16.2M | 0.42% | 98 |
|
2020
Q3 | $35.4M | Buy |
665,016
+268,365
| +68% | +$14.3M | 0.31% | 116 |
|
2020
Q2 | $23.1M | Sell |
396,651
-35,397
| -8% | -$2.06M | 0.22% | 127 |
|
2020
Q1 | $17M | Buy |
432,048
+1,372
| +0.3% | +$54.1K | 0.19% | 135 |
|
2019
Q4 | $25.6M | Buy |
430,676
+1,509
| +0.4% | +$89.7K | 0.2% | 135 |
|
2019
Q3 | $22.8M | Sell |
429,167
-4,871
| -1% | -$259K | 0.21% | 129 |
|
2019
Q2 | $22.2M | Buy |
434,038
+40,424
| +10% | +$2.07M | 0.2% | 134 |
|
2019
Q1 | $20.4M | Sell |
393,614
-174,412
| -31% | -$9.03M | 0.19% | 136 |
|
2018
Q4 | $22.4M | Buy |
568,026
+3,693
| +0.7% | +$145K | 0.24% | 126 |
|
2018
Q3 | $29.1M | Sell |
564,333
-16,608
| -3% | -$856K | 0.26% | 120 |
|
2018
Q2 | $27.2M | Sell |
580,941
-7,980
| -1% | -$374K | 0.25% | 121 |
|
2018
Q1 | $20.9M | Buy |
+588,921
| New | +$20.9M | 0.2% | 135 |
|